Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

574 ARTÍCULOS , VIENDO DEL 241 AL 255

NGF Released from Blood Cells or Collagen Hydrogels as a Therapeutic Target in Alzheimer's Disease?

Humpel C.

Adv Exp Med Biol. 2021;1331:193-202. doi: 10.1007/978-3-030-74046-7_12.

Alzheimer disease and the periodontal patient: New insights, connections, and therapies

Ryder MI, Xenoudi P.

Periodontol 2000. 2021 Oct;87(1):32-42. doi: 10.1111/prd.12389.

Current druggable targets for therapeutic control of Alzheimer's disease

Gupta GL, Samant NP.

Contemp Clin Trials. 2021 Oct;109:106549. doi: 10.1016/j.cct.2021.106549. Epub 2021 Aug 28.

A systematic review of carbohydrate-based bioactive molecules for Alzheimer's disease

Bajad NG, Swetha R, Gutti G, Singh M, Kumar A, Singh SK.

Future Med Chem. 2021 Oct;13(19):1695-1711. doi: 10.4155/fmc-2021-0109. Epub 2021 Sep 2.

Roles of microglia in Alzheimer's disease and impact of new findings on microglial heterogeneity as a target for therapeutic intervention

Takata K, Ginhoux F, Shimohama S.

Biochem Pharmacol. 2021 Oct;192:114754. doi: 10.1016/j.bcp.2021.114754. Epub 2021 Sep 1.

Extensive metabolism of flavonoids relevant to their potential efficacy on Alzheimer's disease

Xia H.

Drug Metab Rev. 2021 Nov;53(4):563-591. doi: 10.1080/03602532.2021.1977316. Epub 2021 Oct 1.

Breaker peptides against amyloid-β aggregation: a potential therapeutic strategy for Alzheimer's disease

Ghosh N, Kundu LM.

Future Med Chem. 2021 Oct;13(20):1767-1794. doi: 10.4155/fmc-2021-0184. Epub 2021 Sep 9.

GPR40 Agonist Ameliorate Pathological Neuroinflammation of Alzheimer's Disease via the Modulation of Gut Microbiota and Immune System, a Mini-Review

Chen J, Li Q, Zhu J, Yuan Z, Wang T, Song J.

Neurotox Res. 2021 Dec;39(6):2175-2185. doi: 10.1007/s12640-021-00408-z. Epub 2021 Sep 10.

Effectiveness of the 10 cm(2) Rivastigmine Patch in Taiwanese Patients with Mild-to-Moderate Alzheimer's Dementia: A 48-Week Real-World Observational Study

Chang CC, Chan L, Chou HH, Yang YW, Chen TF, Chen TB, Chen CI, Yang A, Hu CJ.

Adv Ther. 2021 Oct;38(10):5286-5301. doi: 10.1007/s12325-021-01893-6. Epub 2021 Sep 10.

Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease

Rapaka D, Bitra VR, Challa SR, Adiukwu PC.

Neuropeptides. 2021 Dec;90:102196. doi: 10.1016/j.npep.2021.102196. Epub 2021 Sep 2.

Engrafted stem cell therapy for Alzheimer's disease: A promising treatment strategy with clinical outcome

Salwa, Kumar L.

J Control Release. 2021 Oct 10;338:837-857. doi: 10.1016/j.jconrel.2021.09.007. Epub 2021 Sep 9.

Impact of an educational programme on Alzheimer's disease patients' quality of life: results of the randomized controlled trial THERAD

Villars H, Cantet C, de Peretti E, Perrin A, Soto-Martin M, Gardette V.

Alzheimers Res Ther. 2021 Sep 12;13(1):152. doi: 10.1186/s13195-021-00896-3.

Preclinical and clinical evidence of NAD(+) precursors in health, disease, and ageing

Reiten OK, Wilvang MA, Mitchell SJ, Hu Z, Fang EF.

Mech Ageing Dev. 2021 Oct;199:111567. doi: 10.1016/j.mad.2021.111567. Epub 2021 Sep 10.

Effects of Body Weight on the Safety of High-Dose Donepezil in Alzheimer's Disease: Post hoc Analysis of a Multicenter, Randomized, Open-Label, Parallel Design, Three-Arm Clinical Trial

Hong YJ, Han HJ, Youn YC, Park KW, Yang DW, Kim S, Kim HJ, Kim HJ, Lee Y, Kwon M, Lee JH; ODESA study (Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23 mg).

Dement Geriatr Cogn Disord. 2021;50(3):289-295. doi: 10.1159/000518470. Epub 2021 Sep 10.

Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial

Kim HJ, Cho KR, Jang H, Lee NK, Jung YH, Kim JP, Lee JI, Chang JW, Park S, Kim ST, Moon SW, Seo SW, Choi SJ, Na DL.

Alzheimers Res Ther. 2021 Sep 14;13(1):154. doi: 10.1186/s13195-021-00897-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias